AlphaGrade rates Abbott Laboratories Neutral, with a conviction of 54/100. Fundamental quality looks mixed and the technical setup looks mixed, with notable asymmetric upside — blended with the current market regime.
See the full test-by-test breakdown, ask Alpha about ABT, and find out how it fits your portfolio.
Analyze my portfolio — freeAbbott Laboratories (ABT) has an AlphaGrade conviction of 54/100 — Neutral — as of Jul 28, 2026 · 05:20 UTC, in the current Neutral market regime. AlphaGrade rates Abbott Laboratories Neutral, with a conviction of 54/100. Fundamental quality looks mixed and the technical setup looks mixed, with notable asymmetric upside — blended with the current market regime. This is a transparent, rules-based research opinion, not financial advice.
ABT's conviction is 54/100 (Neutral), built from Quality 55/100, Setup 53/100, and Convex 3.4/5, then adjusted for the market regime.
AlphaGrade blends 20+ signals across four dimensions — Quality (business fundamentals), Setup (technical timing), Convex (asymmetric upside), and the macro regime — recomputed from live data. The same transparent method is applied to every stock and crypto.